These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1103274)

  • 1. Antibodies against equine ALG during treatment of rejection crisis after renal allotransplantation.
    Birkeland SA; Munk-Andersen G
    Scand J Immunol; 1975; 4(4):369-72. PubMed ID: 1103274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled clinical trial of treatment with ALG in established rejection of renal allografts.
    Birkeland SA
    Acta Med Scand; 1975 Dec; 198(6):489-96. PubMed ID: 1108600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR; Blamey RW; Briggs JD; Castro JE; Hamilton DN; Knapp MS; Salaman JR; Sells RA; Williams G; Gowans JL; Peto R; Richards S; Phillips AW; Weinberg AL; Freestone DS
    Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous antilymphocyte globulin in human cadaveric renal allotransplantation. Clinical and immunologic observations.
    Collste LG
    Acta Chir Scand; 1972; 138(8):765-74. PubMed ID: 4565721
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of humoral antibody in the rejection of primary renal allografts in sheep.
    Pedersen NC; Morris B
    J Exp Med; 1974 Sep; 140(3):619-30. PubMed ID: 4607241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW; Jendrisak MD; So SK; McCullough CS; Rush TM; Michalski SM; Phelan D; Mohanakumar T
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
    Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a rosette inhibition test in renal allotransplantation.
    Munro A; Bewick M; Manuel L; Cameron JS; Ellis FG; Boulton-Jones M; Ogg CS
    Br Med J; 1971 Jul; 3(5769):271-6. PubMed ID: 4934045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.
    James K; Pullar DM; Morton JB; Dalton RG; Nolan B; Woodruff MF
    Clin Exp Immunol; 1971 Apr; 8(4):529-42. PubMed ID: 4995934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating antibodies in allograft recipients.
    Revillard JP; Betuel H
    Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration.
    Collste LG
    Acta Chir Scand; 1972; 138(7):661-6. PubMed ID: 4566004
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenicity of aortic valve allografts.
    Heslop BF; Wilson SE; Hardy BE
    Ann Surg; 1973 Mar; 177(3):301-6. PubMed ID: 4144212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.